EZR and breast cancer: Induction of cell migration in triple-negative MDA-MB-231 breast cancer cells led to reduced affiliation of CD44 with lipid raft, and this was accompanied by increased association of CD44 with active ezrin, a membrane-cytoskeleton linker, in the nonraft fraction (Donatello et al, 2012).